On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval

BridgeBio Pharma’s approval of Beyonttra comes three months after the drug landed FDA approval for cardiomyopathy caused by transthyretin amyloidosis. Our recap of recent regulatory news also spans approvals in cancer, immunology, vaccines, and more. The post On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval appeared first on MedCity…

Read More

The Next Cyber Crisis Is Inevitable — and Healthcare Isn’t Ready

There has been increased awareness of healthcare cybersecurity after last year’s massive Change Healthcare breach — but the sector remains dangerously vulnerable to cyberattacks. Experts warn that outdated systems, security staffing shortages and rushed tech adoption are leaving providers too exposed. The post The Next Cyber Crisis Is Inevitable — and Healthcare Isn’t Ready appeared…

Read More